Sanofi Australia

OVERALL
Owned	FRA
Rating

Vaccines and pharmaceuticals wholesaler

Vitamins are manufactured at their Brisbane facility. Other products are imported.

Company Ownership


Sanofi-aventis Australia Pty Ltd	AUS	website	email
Sanofi SA owns 100% of Sanofi-aventis Australia Pty Ltd	FRA	website	email
Vaccines and pharmaceuticals World's largest vaccine company, they also make pharmaceuticals and consumer healthcare products. Previously known as Sanofi-Aventis.

> About the Ratings

Company Assessment

PRAISE

CRITICISM

INFORMATION

Sanofi-aventis Australia Pty Ltd

Australian Packaging Covenant signatory

Signatory to the Australian Packaging Covenant, a voluntary agreement to encourage waste minimisation.
[Source 2017][More on Packaging]

Breaching advertising codes

In 2013, 2012, 2011 and 2010 the Therapeutic Goods Administration's Complaints Resolution Panel upheld complaints about six ads by this company on the grounds that they breached advertising codes. The Panel requested this company withdraw the ads and not to use representations in the ads again.
[Source 2013][More on Irresponsible Marketing]

Political donations

According to the democracyforsale.net website, this company donated $475,870 to Australia's major political parties between 2012 and 2018, as disclosed to the Australian Electoral Commision (AEC).
[Source 2018][More on Politics]

Social responsibility claims

This company has a number of social responsibility claims on its website.
[Source 2014][More on Sustainability Reporting]

No tax paid in 2016/7

According to data released by the Australian Tax Office in Dec 2018, this company was one of 2,159 local and foreign-based companies that paid no tax in Australia in 2016-17. Please note however that companies pay income tax on profits, not revenue (total income). While some companies use tax havens and loopholes to avoid paying their fair share of tax in Australia, other companies that paid no tax have perfectly legitimate reasons.
[Source 2018][More on Finance]

Sanofi SA

CDP Climate Change Score of A-

In 2018, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of A-.
[Source 2018][More on Climate Change]

90/100 SAM Rank

This company received a SAM Rank of 90/100 in the Pharmaceuticals category of the 2018 SAM Corporate Sustainability Assessment. The index is based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
[Source 2018][More on Sustainability Reporting]

CDP Water Security Score of B

In 2018, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security Score of B.
[Source 2018][More on Human Rights]

100% on Corporate Equality Index

This company is listed as having best practice on a report card on lesbian, gay, bisexual and transgender equality in corporate America.
[Source 2019][More on Workers Rights]

Global 100

The 2020 Global 100 Most Sustainable Corporations in the World list is an extensive data-driven corporate sustainability assessment. The ranked companies are leaders in the field of a sustainable business approach. The efficiency of a company's energy, water, CO2 and waste management is measured in relation to its total sales volume. The disclosure of that information is a pre-condition for the assessment. Of the 123 companies in its peer group, this company ranked #1.
[Source 2020][More on Sustainability Reporting]

Supply chain practices in China

This company received a score of 8.5/100 (retrieved 25-Feb-2020) in the Corporate Information Transparency Index (CITI), a system for evaluating supply chain practices in China, particularly in regards to environmental management and water pollution. Scores are calculated using government compliance data, online monitoring data, and third-party environmental audits, as well as trends in the environmental performance of factories in the company's supply chains.
[Source 2020][More on Habitats]

Conflict minerals rating

As You Sow's 2018 report, Mining the Disclosures, is a deep analysis of 206 companies' human rights performance in relation to sourcing conflict minerals from the Democratic Republic of the Congo (DRC). This company's score was below 40% (Weak).
[Source 2018][More on Human Rights]

Cartel fine in India

In June 2015, Sanofi's Indian subsidiary was fined US$9.4m by the Indian Competition Commission for colluding and forming a cartel (with GlaxoSmithKline) in their bidding practices to get government contracts for the supply of a meningitis vaccine. The vaccine was for use among 200,000 pilgrims visiting Mecca.
[Source 2015][More on Finance]

False claims settlement

In 2012, the US Department of Justice announced that this company agreed to pay US$109m to resolve allegations that they violated the False Claims Act by giving doctors free samples of knee injection product Hylagan to encourage them to buy and prescribe the treatment. The settlement also resolved allegations that the company submitted false sales reports for Hylagan that did not account for the free samples distributed contingent on purchases of the product.
[Source 2014][More on Governance]

Fined for bribery

This company was fined 28m euros because two of its former employees were convicted of bribery by a German court in December 2013. The former employees had made illicit payments to a consultancy advising one of this company's clients between 2007 and 2010 to win new orders for the client. This led to Sanofi being unfairly given preference.
[Source 2014][More on Finance]

Antitrust fine upheld

The Court of Appeals of Paris upheld a 40.6m euro antitrust fine against this company for campaigning to discourage doctors and pharmacists from prescribing or substituting a generic version of its blood thinner Plavix. The Court rejected this company's appeal of a May 2013 decision by the French Competition Authority and fining it for abusing its dominance and using a 'strategy of denigration' against generic Plavix competitors in 2009 and 2010.
[Source 2014][More on Finance]

49.9% in Newsweek Green Ranking 2017

This company received a score of 49.9/100 in the Newsweek Green Ranking 2017, which ranks the world's largest publicly traded companies on eight indicators covering energy, greenhouse gases, water, waste, fines and penalties, linking executive pay to sustainability targets, board-level committee oversight of environmental issues and third-party audits. Ranking methodology by Corporate Knights and HIP Investor.
[Source 2017][More on Sustainability Reporting]

Fined for pricing dispute

Azmacort, Nasacort and Nasacort AQ are all steroid-based anti-inflammatory nasal sprays used to treat nasal congestion during the onset of a sinus infection, the common cold or hay fever. Their manufacturer, Aventis Pharmaceutical, which is a subsidiary of Sanofi-Aventis, agreed to $95.5 million in fines in 2009 after the company was found to have misreported the drugs' best prices, thereby avoiding paying millions of dollars in rebates to Medicaid between 1995 and 2000. [Listed under Information due to age of court finding]
[Source 2009][More on Governance]

Governance

Sanofi-Aventis has been investigated by USA's Food and Drug Administration for supplying the agency with fraudulent clinical trial data. Sanofi has run into legal trouble in the form of anti-trust lawsuits and investigations for its suppression of generic drugs and fiercely protecting its patents.
[Source 2009][More on Governance]

Fines for misconduct

This company is listed on the Federal Contractor Misconduct Database as having 8 instances of misconduct since 1995 amounting to US$290 million in penalties.
[Source 2014][More on Governance]

'Health camps' in India

This company is one of the pharmaceutical companies using free 'health camps' in India to test poor patients for diseases and then prescribe them drugs. In violation of the regulations of the Medical Council of India, the camps often do not have licensed doctors but use drug sales representatives to undertake health checks.
[Source 2015][More on Governance]

Corporate responsibility claims

This company has a number of corporate responsibility claims and documents on its website.
[Source 2013][More on Sustainability Reporting]

Access to Medicine ranking

This company received the seventh highest score in the Access to Medicine Index 2018, a ranking of the world's largest pharmaceutical companies on their efforts to increase access to medicine in developing countries.
[Source 2018][More on Human Rights]

> About the Icons

Company Details

Company Structure	Wholly-owned subsidiary
# Employees	1,000 in 2015 in Australia
Aus Manufacturing	Yes

Contact Details

Address	Talavera Corporate Centre, Building D, 12-24 Talavera Road, Macquarie Park, NSW, 2113, Australia
Phone	02 8666 2000
Fax	02 8666 3000
Website	www.sanofi.com.au

Products / Brands

Sanofi Australia

Betadine Antiseptic
Betadine Cold & Flu
Bio-Organics Vitamins
Cenovis Vitamins
Ford Senna Laxatives
Gastrolyte Digestive Care
I Quit Sugar Health Foods
MICROgenics Vitamins

Nature's Own Vitamins
Nature's Own Health Foods
Ostelin Vitamins
Selsun Shampoo
Shave Mens Grooming
Telfast Cold & Flu

Sanofi Australia

OVERALL

Company Ownership

Company Assessment

Company Details

Contact Details

Products / Brands

Featured Pages

Connect

Legal